Prescribers and Naloxone Pharmacy Claims

Journal of General Internal Medicine - Germany
doi 10.1007/s11606-020-05760-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Naloxone Accessibility Without a Prescriber Encounter Under Standing Orders at Community Pharmacy Chains in Texas

JAMA - Journal of the American Medical Association
Medicine
2018English

Approach to Addressing Missing Data for Electronic Medical Records and Pharmacy Claims Data Research

Pharmacotherapy
Pharmacology
2015English

Pcn272 - Analysis of Pharmacy Claims for High Cost Drugs: Lenalidomide Utilisation and Expenditure in Ireland

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

PRS50 Is It Appropriate to Measure Asthma Controller Adherence Using Pharmacy Claims Data?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Validity Assessment of Self-Reported Medication Use by Comparing to Pharmacy Insurance Claims

BMJ Open
Medicine
2015English

A Large Pharmacy Claims-Based Descriptive Analysis of Patients With Migraine and Associated Pharmacologic Treatment Patterns

Neuropsychiatric Disease and Treatment
PsychiatryMental HealthBiological Psychiatry
2011English

Prescribers Are Increasingly Circumvented

British Medical Journal
Medicine
2004English

Community Pharmacy Naloxone Supply, Before and After Rescheduling as an Over‐the‐counter Drug: Sales and Prescriptions Data, 2014–2018

Medical Journal of Australia
Medicine
2020English

Guides for Users and Prescribers of Lithium

International Journal of Bipolar Disorders
PsychiatryMental HealthBiological Psychiatry
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy